Loading…

Nifedipine Prevents Changes in Nitric Oxide Synthase mRNA Levels Induced by Cyclosporine

Cyclosporine toxicity mainly affects kidney and liver function. We have previously shown that cyclosporine nephrotoxicity alters kidney nitric oxide synthase mRNA pattern of expression. To determine if nitric oxide synthase expression changes are mediated directly by cyclosporine or by secondary hem...

Full description

Saved in:
Bibliographic Details
Published in:Hypertension (Dallas, Tex. 1979) Tex. 1979), 2000-10, Vol.36 (4), p.642-647
Main Authors: Sánchez-Lozada, Laura G, Gamba, Gerardo, Bolio, Alexis, Jiménez, Fabiola, Herrera-Acosta, Jaime, Bobadilla, Norma A
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c4752-3f6b2a422c4b1d4448aab46bfb01cecd18b4263f42b9983871889076c55e5b8f3
cites cdi_FETCH-LOGICAL-c4752-3f6b2a422c4b1d4448aab46bfb01cecd18b4263f42b9983871889076c55e5b8f3
container_end_page 647
container_issue 4
container_start_page 642
container_title Hypertension (Dallas, Tex. 1979)
container_volume 36
creator Sánchez-Lozada, Laura G
Gamba, Gerardo
Bolio, Alexis
Jiménez, Fabiola
Herrera-Acosta, Jaime
Bobadilla, Norma A
description Cyclosporine toxicity mainly affects kidney and liver function. We have previously shown that cyclosporine nephrotoxicity alters kidney nitric oxide synthase mRNA pattern of expression. To determine if nitric oxide synthase expression changes are mediated directly by cyclosporine or by secondary hemodynamic alterations induced by cyclosporine, we evaluated if these effects are tissue specific and if nifedipine-induced vasodilation prevents these alterations. Uninephrectomized Wistar rats treated for 7 days with olive oil, cyclosporine (30 mg/kg), nifedipine (3 mg/kg), and nifedipine+cyclosporine were studied. In vehicle and cyclosporine groups, the gene expression of the neuronal, inducible, and endothelial nitric oxide synthases in cerebellum, heart, intestine, liver, renal cortex, and medulla was evaluated. The administration of cyclosporine was associated with nephrotoxicity and hepatotoxicity, increased endothelial nitric oxide synthase mRNA levels in renal cortex and liver, and a decrease in inducible nitric oxide synthase and neuronal nitric oxide synthase in renal medulla. The mRNA levels of the 3 nitric oxide synthase isoforms were not affected in any other tissue. Nifedipine did not alter nitric oxide synthase expression in the control group but prevented changes associated with cyclosporine. These results suggest that cyclosporine-induced changes in the pattern of expression of the nitric oxide synthases may be secondary to its hemodynamic effects.
doi_str_mv 10.1161/01.HYP.36.4.642
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_205301116</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>62757796</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4752-3f6b2a422c4b1d4448aab46bfb01cecd18b4263f42b9983871889076c55e5b8f3</originalsourceid><addsrcrecordid>eNpFkNFv0zAQhy3ExMrgmTdkwXMyn31OnMepAjap6qZtSOPJsh2HeqRJZyeM_vd4agWWTvZJn39nf4R8AFYCVHDOoLz8cVOKqsSyQv6KLEByLFBW4jVZMGiwaAAeTsnblB4ZA0Ss35BTAIaMS1iQh3XofBt2YfD0JvrffpgSXW7M8NMnGga6DlMMjl7_Ca2nd_th2pjk6fZ2fUFXme4TvRra2fmW2j1d7l0_pt0Yc9o7ctKZPvn3x_2MfP_65X55Wayuv10tL1aFw1ryQnSV5QY5d2ihzc9TxlisbGcZOO9aUBZ5JTrktmmUUDUo1bC6clJ6aVUnzsinQ-4ujk-zT5N-HOc45JGaMykYZE8ZOj9ALo4pRd_pXQxbE_camH4RqRnoLFKLSqPOIvONj8fY2W59-58_msvA5yNgkjN9F83gQvrH1Y2sUWUKD9Tz2E8-pl_9_Oyj3njTTxvN8sq_UwXPB3jpilyCi79g4YkX</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>205301116</pqid></control><display><type>article</type><title>Nifedipine Prevents Changes in Nitric Oxide Synthase mRNA Levels Induced by Cyclosporine</title><source>EZB Electronic Journals Library</source><creator>Sánchez-Lozada, Laura G ; Gamba, Gerardo ; Bolio, Alexis ; Jiménez, Fabiola ; Herrera-Acosta, Jaime ; Bobadilla, Norma A</creator><creatorcontrib>Sánchez-Lozada, Laura G ; Gamba, Gerardo ; Bolio, Alexis ; Jiménez, Fabiola ; Herrera-Acosta, Jaime ; Bobadilla, Norma A</creatorcontrib><description>Cyclosporine toxicity mainly affects kidney and liver function. We have previously shown that cyclosporine nephrotoxicity alters kidney nitric oxide synthase mRNA pattern of expression. To determine if nitric oxide synthase expression changes are mediated directly by cyclosporine or by secondary hemodynamic alterations induced by cyclosporine, we evaluated if these effects are tissue specific and if nifedipine-induced vasodilation prevents these alterations. Uninephrectomized Wistar rats treated for 7 days with olive oil, cyclosporine (30 mg/kg), nifedipine (3 mg/kg), and nifedipine+cyclosporine were studied. In vehicle and cyclosporine groups, the gene expression of the neuronal, inducible, and endothelial nitric oxide synthases in cerebellum, heart, intestine, liver, renal cortex, and medulla was evaluated. The administration of cyclosporine was associated with nephrotoxicity and hepatotoxicity, increased endothelial nitric oxide synthase mRNA levels in renal cortex and liver, and a decrease in inducible nitric oxide synthase and neuronal nitric oxide synthase in renal medulla. The mRNA levels of the 3 nitric oxide synthase isoforms were not affected in any other tissue. Nifedipine did not alter nitric oxide synthase expression in the control group but prevented changes associated with cyclosporine. These results suggest that cyclosporine-induced changes in the pattern of expression of the nitric oxide synthases may be secondary to its hemodynamic effects.</description><identifier>ISSN: 0194-911X</identifier><identifier>EISSN: 1524-4563</identifier><identifier>DOI: 10.1161/01.HYP.36.4.642</identifier><identifier>PMID: 11040251</identifier><identifier>CODEN: HPRTDN</identifier><language>eng</language><publisher>Philadelphia, PA: American Heart Association, Inc</publisher><subject>Animals ; Biological and medical sciences ; Body Weight - drug effects ; Cyclosporine - pharmacology ; Cyclosporine - toxicity ; Drug toxicity and drugs side effects treatment ; Glomerular Filtration Rate - drug effects ; Glyceraldehyde-3-Phosphate Dehydrogenases - metabolism ; Isoenzymes - genetics ; Isoenzymes - metabolism ; Kidney Cortex - drug effects ; Kidney Cortex - enzymology ; Kidney Medulla - drug effects ; Kidney Medulla - enzymology ; Liver - drug effects ; Liver - enzymology ; Liver Function Tests ; Male ; Medical sciences ; Nephrectomy ; Nifedipine - pharmacology ; Nitric Oxide Synthase - drug effects ; Nitric Oxide Synthase - genetics ; Nitric Oxide Synthase - metabolism ; Nitric Oxide Synthase Type I ; Nitric Oxide Synthase Type II ; Nitric Oxide Synthase Type III ; Organ Specificity ; Pharmacology. Drug treatments ; Rats ; Rats, Wistar ; RNA, Messenger - drug effects ; RNA, Messenger - metabolism ; Toxicity: urogenital system</subject><ispartof>Hypertension (Dallas, Tex. 1979), 2000-10, Vol.36 (4), p.642-647</ispartof><rights>2000 American Heart Association, Inc.</rights><rights>2001 INIST-CNRS</rights><rights>Copyright American Heart Association, Inc. Oct 2000</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4752-3f6b2a422c4b1d4448aab46bfb01cecd18b4263f42b9983871889076c55e5b8f3</citedby><cites>FETCH-LOGICAL-c4752-3f6b2a422c4b1d4448aab46bfb01cecd18b4263f42b9983871889076c55e5b8f3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>309,310,314,776,780,785,786,23909,23910,25118,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=795748$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11040251$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Sánchez-Lozada, Laura G</creatorcontrib><creatorcontrib>Gamba, Gerardo</creatorcontrib><creatorcontrib>Bolio, Alexis</creatorcontrib><creatorcontrib>Jiménez, Fabiola</creatorcontrib><creatorcontrib>Herrera-Acosta, Jaime</creatorcontrib><creatorcontrib>Bobadilla, Norma A</creatorcontrib><title>Nifedipine Prevents Changes in Nitric Oxide Synthase mRNA Levels Induced by Cyclosporine</title><title>Hypertension (Dallas, Tex. 1979)</title><addtitle>Hypertension</addtitle><description>Cyclosporine toxicity mainly affects kidney and liver function. We have previously shown that cyclosporine nephrotoxicity alters kidney nitric oxide synthase mRNA pattern of expression. To determine if nitric oxide synthase expression changes are mediated directly by cyclosporine or by secondary hemodynamic alterations induced by cyclosporine, we evaluated if these effects are tissue specific and if nifedipine-induced vasodilation prevents these alterations. Uninephrectomized Wistar rats treated for 7 days with olive oil, cyclosporine (30 mg/kg), nifedipine (3 mg/kg), and nifedipine+cyclosporine were studied. In vehicle and cyclosporine groups, the gene expression of the neuronal, inducible, and endothelial nitric oxide synthases in cerebellum, heart, intestine, liver, renal cortex, and medulla was evaluated. The administration of cyclosporine was associated with nephrotoxicity and hepatotoxicity, increased endothelial nitric oxide synthase mRNA levels in renal cortex and liver, and a decrease in inducible nitric oxide synthase and neuronal nitric oxide synthase in renal medulla. The mRNA levels of the 3 nitric oxide synthase isoforms were not affected in any other tissue. Nifedipine did not alter nitric oxide synthase expression in the control group but prevented changes associated with cyclosporine. These results suggest that cyclosporine-induced changes in the pattern of expression of the nitric oxide synthases may be secondary to its hemodynamic effects.</description><subject>Animals</subject><subject>Biological and medical sciences</subject><subject>Body Weight - drug effects</subject><subject>Cyclosporine - pharmacology</subject><subject>Cyclosporine - toxicity</subject><subject>Drug toxicity and drugs side effects treatment</subject><subject>Glomerular Filtration Rate - drug effects</subject><subject>Glyceraldehyde-3-Phosphate Dehydrogenases - metabolism</subject><subject>Isoenzymes - genetics</subject><subject>Isoenzymes - metabolism</subject><subject>Kidney Cortex - drug effects</subject><subject>Kidney Cortex - enzymology</subject><subject>Kidney Medulla - drug effects</subject><subject>Kidney Medulla - enzymology</subject><subject>Liver - drug effects</subject><subject>Liver - enzymology</subject><subject>Liver Function Tests</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Nephrectomy</subject><subject>Nifedipine - pharmacology</subject><subject>Nitric Oxide Synthase - drug effects</subject><subject>Nitric Oxide Synthase - genetics</subject><subject>Nitric Oxide Synthase - metabolism</subject><subject>Nitric Oxide Synthase Type I</subject><subject>Nitric Oxide Synthase Type II</subject><subject>Nitric Oxide Synthase Type III</subject><subject>Organ Specificity</subject><subject>Pharmacology. Drug treatments</subject><subject>Rats</subject><subject>Rats, Wistar</subject><subject>RNA, Messenger - drug effects</subject><subject>RNA, Messenger - metabolism</subject><subject>Toxicity: urogenital system</subject><issn>0194-911X</issn><issn>1524-4563</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2000</creationdate><recordtype>article</recordtype><recordid>eNpFkNFv0zAQhy3ExMrgmTdkwXMyn31OnMepAjap6qZtSOPJsh2HeqRJZyeM_vd4agWWTvZJn39nf4R8AFYCVHDOoLz8cVOKqsSyQv6KLEByLFBW4jVZMGiwaAAeTsnblB4ZA0Ss35BTAIaMS1iQh3XofBt2YfD0JvrffpgSXW7M8NMnGga6DlMMjl7_Ca2nd_th2pjk6fZ2fUFXme4TvRra2fmW2j1d7l0_pt0Yc9o7ctKZPvn3x_2MfP_65X55Wayuv10tL1aFw1ryQnSV5QY5d2ihzc9TxlisbGcZOO9aUBZ5JTrktmmUUDUo1bC6clJ6aVUnzsinQ-4ujk-zT5N-HOc45JGaMykYZE8ZOj9ALo4pRd_pXQxbE_camH4RqRnoLFKLSqPOIvONj8fY2W59-58_msvA5yNgkjN9F83gQvrH1Y2sUWUKD9Tz2E8-pl_9_Oyj3njTTxvN8sq_UwXPB3jpilyCi79g4YkX</recordid><startdate>200010</startdate><enddate>200010</enddate><creator>Sánchez-Lozada, Laura G</creator><creator>Gamba, Gerardo</creator><creator>Bolio, Alexis</creator><creator>Jiménez, Fabiola</creator><creator>Herrera-Acosta, Jaime</creator><creator>Bobadilla, Norma A</creator><general>American Heart Association, Inc</general><general>Lippincott</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>K9.</scope></search><sort><creationdate>200010</creationdate><title>Nifedipine Prevents Changes in Nitric Oxide Synthase mRNA Levels Induced by Cyclosporine</title><author>Sánchez-Lozada, Laura G ; Gamba, Gerardo ; Bolio, Alexis ; Jiménez, Fabiola ; Herrera-Acosta, Jaime ; Bobadilla, Norma A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4752-3f6b2a422c4b1d4448aab46bfb01cecd18b4263f42b9983871889076c55e5b8f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2000</creationdate><topic>Animals</topic><topic>Biological and medical sciences</topic><topic>Body Weight - drug effects</topic><topic>Cyclosporine - pharmacology</topic><topic>Cyclosporine - toxicity</topic><topic>Drug toxicity and drugs side effects treatment</topic><topic>Glomerular Filtration Rate - drug effects</topic><topic>Glyceraldehyde-3-Phosphate Dehydrogenases - metabolism</topic><topic>Isoenzymes - genetics</topic><topic>Isoenzymes - metabolism</topic><topic>Kidney Cortex - drug effects</topic><topic>Kidney Cortex - enzymology</topic><topic>Kidney Medulla - drug effects</topic><topic>Kidney Medulla - enzymology</topic><topic>Liver - drug effects</topic><topic>Liver - enzymology</topic><topic>Liver Function Tests</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Nephrectomy</topic><topic>Nifedipine - pharmacology</topic><topic>Nitric Oxide Synthase - drug effects</topic><topic>Nitric Oxide Synthase - genetics</topic><topic>Nitric Oxide Synthase - metabolism</topic><topic>Nitric Oxide Synthase Type I</topic><topic>Nitric Oxide Synthase Type II</topic><topic>Nitric Oxide Synthase Type III</topic><topic>Organ Specificity</topic><topic>Pharmacology. Drug treatments</topic><topic>Rats</topic><topic>Rats, Wistar</topic><topic>RNA, Messenger - drug effects</topic><topic>RNA, Messenger - metabolism</topic><topic>Toxicity: urogenital system</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sánchez-Lozada, Laura G</creatorcontrib><creatorcontrib>Gamba, Gerardo</creatorcontrib><creatorcontrib>Bolio, Alexis</creatorcontrib><creatorcontrib>Jiménez, Fabiola</creatorcontrib><creatorcontrib>Herrera-Acosta, Jaime</creatorcontrib><creatorcontrib>Bobadilla, Norma A</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><jtitle>Hypertension (Dallas, Tex. 1979)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sánchez-Lozada, Laura G</au><au>Gamba, Gerardo</au><au>Bolio, Alexis</au><au>Jiménez, Fabiola</au><au>Herrera-Acosta, Jaime</au><au>Bobadilla, Norma A</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Nifedipine Prevents Changes in Nitric Oxide Synthase mRNA Levels Induced by Cyclosporine</atitle><jtitle>Hypertension (Dallas, Tex. 1979)</jtitle><addtitle>Hypertension</addtitle><date>2000-10</date><risdate>2000</risdate><volume>36</volume><issue>4</issue><spage>642</spage><epage>647</epage><pages>642-647</pages><issn>0194-911X</issn><eissn>1524-4563</eissn><coden>HPRTDN</coden><abstract>Cyclosporine toxicity mainly affects kidney and liver function. We have previously shown that cyclosporine nephrotoxicity alters kidney nitric oxide synthase mRNA pattern of expression. To determine if nitric oxide synthase expression changes are mediated directly by cyclosporine or by secondary hemodynamic alterations induced by cyclosporine, we evaluated if these effects are tissue specific and if nifedipine-induced vasodilation prevents these alterations. Uninephrectomized Wistar rats treated for 7 days with olive oil, cyclosporine (30 mg/kg), nifedipine (3 mg/kg), and nifedipine+cyclosporine were studied. In vehicle and cyclosporine groups, the gene expression of the neuronal, inducible, and endothelial nitric oxide synthases in cerebellum, heart, intestine, liver, renal cortex, and medulla was evaluated. The administration of cyclosporine was associated with nephrotoxicity and hepatotoxicity, increased endothelial nitric oxide synthase mRNA levels in renal cortex and liver, and a decrease in inducible nitric oxide synthase and neuronal nitric oxide synthase in renal medulla. The mRNA levels of the 3 nitric oxide synthase isoforms were not affected in any other tissue. Nifedipine did not alter nitric oxide synthase expression in the control group but prevented changes associated with cyclosporine. These results suggest that cyclosporine-induced changes in the pattern of expression of the nitric oxide synthases may be secondary to its hemodynamic effects.</abstract><cop>Philadelphia, PA</cop><cop>Hagerstown, MD</cop><pub>American Heart Association, Inc</pub><pmid>11040251</pmid><doi>10.1161/01.HYP.36.4.642</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0194-911X
ispartof Hypertension (Dallas, Tex. 1979), 2000-10, Vol.36 (4), p.642-647
issn 0194-911X
1524-4563
language eng
recordid cdi_proquest_journals_205301116
source EZB Electronic Journals Library
subjects Animals
Biological and medical sciences
Body Weight - drug effects
Cyclosporine - pharmacology
Cyclosporine - toxicity
Drug toxicity and drugs side effects treatment
Glomerular Filtration Rate - drug effects
Glyceraldehyde-3-Phosphate Dehydrogenases - metabolism
Isoenzymes - genetics
Isoenzymes - metabolism
Kidney Cortex - drug effects
Kidney Cortex - enzymology
Kidney Medulla - drug effects
Kidney Medulla - enzymology
Liver - drug effects
Liver - enzymology
Liver Function Tests
Male
Medical sciences
Nephrectomy
Nifedipine - pharmacology
Nitric Oxide Synthase - drug effects
Nitric Oxide Synthase - genetics
Nitric Oxide Synthase - metabolism
Nitric Oxide Synthase Type I
Nitric Oxide Synthase Type II
Nitric Oxide Synthase Type III
Organ Specificity
Pharmacology. Drug treatments
Rats
Rats, Wistar
RNA, Messenger - drug effects
RNA, Messenger - metabolism
Toxicity: urogenital system
title Nifedipine Prevents Changes in Nitric Oxide Synthase mRNA Levels Induced by Cyclosporine
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-04T12%3A20%3A58IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Nifedipine%20Prevents%20Changes%20in%20Nitric%20Oxide%20Synthase%20mRNA%20Levels%20Induced%20by%20Cyclosporine&rft.jtitle=Hypertension%20(Dallas,%20Tex.%201979)&rft.au=S%C3%A1nchez-Lozada,%20Laura%20G&rft.date=2000-10&rft.volume=36&rft.issue=4&rft.spage=642&rft.epage=647&rft.pages=642-647&rft.issn=0194-911X&rft.eissn=1524-4563&rft.coden=HPRTDN&rft_id=info:doi/10.1161/01.HYP.36.4.642&rft_dat=%3Cproquest_cross%3E62757796%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c4752-3f6b2a422c4b1d4448aab46bfb01cecd18b4263f42b9983871889076c55e5b8f3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=205301116&rft_id=info:pmid/11040251&rfr_iscdi=true